http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35258612

Outgoing Links

Predicate Object
contentType Randomized Controlled Trial|Clinical Trial, Phase II|Journal Article|Research Support, Non-U.S. Gov't
issn 0920-1211
pageRange 107112-
publicationName Epilepsy Research
startingPage 107112
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_daf18e2cff61a159c33ab55509b953ec
bibliographicCitation Sullivan J, Gunning B, Zafar M, Guerrini R, Gecz J, Kolc KL, Zhao Y, Gasior M, Aimetti AA, Samanta D. Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy. Epilepsy Res. 2023 Mar;191():107112. doi: 10.1016/j.eplepsyres.2023.107112. PMID: 36870093.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da7f77088fc838faa126a17798d8454a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2dbdfcbc66d83b63fdac9f79cd74eae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dba20f5b2378035c45fdd99dfbc1ad5f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e87926bdca28b5c8992c532c19c32cc3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_442c607876201f34aea574896d2a0f0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e359f2326cceca0249bfac6eceb25547
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6429d748a294e978022f0e3acf89cee2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e15dcc407219216f5eb4a2e47a20721
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cbd0e1ee1d1cea796b82087bed263f5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64ceb91afd83bb2b062809247a5774c8
date 202303
identifier https://pubmed.ncbi.nlm.nih.gov/36870093
https://doi.org/10.1016/j.eplepsyres.2023.107112
isPartOf https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy
discusses http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0403968
http://id.nlm.nih.gov/mesh/M0274194
http://id.nlm.nih.gov/mesh/M0017509
http://id.nlm.nih.gov/mesh/M000748785
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000927Q000627
http://id.nlm.nih.gov/mesh/D004829Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000091363
http://id.nlm.nih.gov/mesh/D012640Q000188
http://id.nlm.nih.gov/mesh/D016000
http://id.nlm.nih.gov/mesh/D011280Q000627
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D002648
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918305
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6654
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3080643
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21155376
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9264
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3306a002c570ef53ef5168db67b13b4d

Total number of triples: 51.